About Contact Us Careers

CAR T-Cell Therapy Market Size

Request Free Sample Copy

Report ID: 2441
Published Date: Oct 09, 2024
Report Format: PDF, PPT

Buy Now

CAR T-Cell Therapy Market Size

CAR T-Cell Therapy Market size was over USD 4.62 billion in 2023 and is anticipated to cross USD 109.82 billion by 2036, growing at more than 27.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of CAR T-cell therapy is estimated at USD 5.64 billion.

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

CAR T-Cell Therapy Market Size & Share, Growth Forecast 2036

Author Credits: Radhika Pawar

Report ID: 2441
Published Date: Oct 09, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing research resulting in development of effective targeted therapies such as CAR T-cell therapy and growing cases of cancer are factors driving the market growth.

The market is anticipated to attain a CAGR of 35% over the forecast period, i.e. 2020-2028.

North America is anticipated to provide more business opportunities for growth on account of growing FDA approvals of therapies in the United States.

The major players in the market are Novartis International AG, Gilead Sciences, Inc., Pfizer Inc., Johnson & Johnson, Amgen Inc., Bellicum Pharmaceuticals, Inc., Immune Therapeutics, Sorrento Therapeutics, Celgene Corporation and Bluebird Bio.

Inquiry Before Buying Request Free Sample